₩ 1198
Key Takeaways
Risk factor
Poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Yungjin Pharm. Co., Ltd. is a pharmaceutical enterprise based in Seoul, South Korea, with origins dating back to 1952. The company's product offerings encompass a variety of medical and health-related items, such as cephalosporin antibiotics, antipsychotic medications, cardiovascular treatments, and nutritional supplements. It operates as a subsidiary under the ownership of KT&G Corporation.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA.
Data is available to registered users only